CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 90 enrolled
Drug / intervention
intravenous injection of propofol only +1 moredrug
Likely dose
intravenous injection of propofol only 2 mg/kgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06574945
NCT06574945Phase 4Completed

Efficacy and Safety of Propofol in Combination With Different Esketamine Doses for Anesthesia During Loop Electrosurgical Excision Procedure

Qian Wu·interventional·Posted Aug 28, 2024·Updated Aug 28, 2024

In Brief

A Phase 4 clinical trial evaluating intravenous injection of propofol only and intravenous injection of propofol +esketamine for Esketamine and 2 related conditions. Completed, enrolled 90 participants across 1 site.

Detailed Summary

The goal of this prospective, randomized controlled study study is to investigate the efficacy and safety of propofol combined with different doses of esketamine (ESK) for anesthesia during loop electrosurgical excision procedure (LEEP).Ninety female patients undergoing LEEP were randomly allocated to three groups.It aims to answer :1.The effect of esketamine combined with propofol in respiration, circulation, etc,during LEEP. 2.The appropriate dosage of esketamine when combined with propofol in LEEP anesthesia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesChina
Collaborators--

Timeline

Phase 4CompletedFinished
20222023202420252026
First PostedAug 28, 2024
Enrollment StartJan 7, 2022
Primary CompletionJan 7, 2022
Study CompletionOct 28, 2022
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 1.8 years ago

Interventions

intravenous injection of propofol onlydrug

Propofol was administered intravenously 2 mg/kg

intravenous injection of propofol +esketaminedrug

intravenous injection of 0.5 mg/kg ESK followed by 1.5 mg/kg of propofol or intravenous injection of 0.25 mg/kg ESK followed by 1.5 mg/kg of propofol